You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

495 Results
Document
Feb 2020
Document
Feb 2020
Document
Feb 2020
Document
Feb 2020
Document
Feb 2020
Document
Feb 2020
Document
Apr 2020
Document
Apr 2020
This page is for people newly diagnosed with ALL.
Guidelines and Advice
Status: In-Review
ID: 3-22
Version: N/A
Apr 2020
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Azacitidine in combination with Venetoclax (Outpatient) - Previously Untreated Acute Myeloid Leukemia
Exceptional Access Program
    venetoclax - Venetoclax in combination with azacitidine - Previously untreated acute myeloid leukemia
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
azaCITIDine,
venetoclax
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2022
Document
Sep 2020

Pages